Latest & greatest articles for chronic kidney disease

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on chronic kidney disease or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on chronic kidney disease and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for chronic kidney disease

61. Chronic kidney disease

Chronic kidney disease Chronic kidney disease - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Chronic kidney disease Last reviewed: August 2018 Last updated: November 2017 Summary Proteinuria or haematuria, and/or a reduction in the GFR for more than 3 months' duration. The most common causes are diabetes mellitus (DM) and hypertension (HTN). The majority of people are asymptomatic, and the diagnosis is determined (...) only by laboratory studies. Glycaemic control for diabetic nephropathy and optimisation of BP are key in slowing the progression of disease. Increased risk for cardiovascular disease. Definition Chronic kidney disease, also known as chronic renal failure, is defined by either a pathological abnormality of the kidney, such as haematuria and/or proteinuria, or a reduction in the GFR to <60 mL/minute/1.73 m^2 for ≥3 months' duration. KDOQI Advisory Board Members. Clinical practice guidelines

BMJ Best Practice2017

62. Association of British Clinical Diabetologists - Renal Association (ABCD-RA) Clinical Practice Guidelines for Management of Lipids in Adults with Diabetes Mellitus and Nephropathy and/or Chronic Kidney Disease

Association of British Clinical Diabetologists - Renal Association (ABCD-RA) Clinical Practice Guidelines for Management of Lipids in Adults with Diabetes Mellitus and Nephropathy and/or Chronic Kidney Disease

Association of British Clinical Diabetologists2017

63. Hypertension management and renin-angiotensin-aldosterone system blockade in patients with diabetes, nephropathy and/or chronic kidney disease

Hypertension management and renin-angiotensin-aldosterone system blockade in patients with diabetes, nephropathy and/or chronic kidney disease

Association of British Clinical Diabetologists2017

65. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)

KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)

National Kidney Foundation2017

67. Hypertension management and use of antihypertensive medication in patients with chronic kidney disease

Hypertension management and use of antihypertensive medication in patients with chronic kidney disease

DynaMed Plus2017

74. Urinary Calcium Excretion and Risk of Chronic Kidney Disease in the General Population

Urinary Calcium Excretion and Risk of Chronic Kidney Disease in the General Population 29318214 2018 11 13 2468-0249 2 3 2017 May Kidney international reports Kidney Int Rep Urinary Calcium Excretion and Risk of Chronic Kidney Disease in the General Population. 366-379 10.1016/j.ekir.2016.12.007 High urinary calcium excretion (UCaE) has been shown to lead to accelerated renal function decline in individuals with renal tubular diseases. It is not known whether this association also exists (...) in the general population. Therefore, we investigated whether high UCaE is associated with risk of developing chronic kidney disease (CKD) in community-dwelling subjects. Urine samples of 5491 subjects who were free of CKD at baseline and participated in the Prevention of Renal and Vascular End-Stage Disease study (a prospective, observational, general population-based cohort of Dutch men and women aged 28-75 years) were examined for UCaE. UCa concentration was measured in two 24-hour urine samples

Kidney international reports2016 Full Text: Link to full Text with Trip Pro

75. Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity—A Prospective Randomized Double-Blinded Placebo-Controlled Clinical Trial

Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity—A Prospective Randomized Double-Blinded Placebo-Controlled Clinical Trial 29142966 2018 11 13 2468-0249 2 3 2017 May Kidney international reports Kidney Int Rep Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity-A Prospective Randomized Double-Blinded Placebo-Controlled (...) Clinical Trial. 380-389 10.1016/j.ekir.2016.12.008 Chronic kidney disease (CKD) is associated with high cardiovascular morbidity and mortality. Recent evidence suggests that increases in both serum and intracellular magnesium (Mg) can slow or even prevent the development of vascular calcification seen in CKD. Serum calcification propensity ( T 50 ) is a novel functional test, which is associated with all-cause mortality in CKD and measures the ability of serum to delay the formation of crystalline

Kidney international reports2016 Full Text: Link to full Text with Trip Pro

76. Chronic Kidney Disease.

Chronic Kidney Disease. The definition and classification of chronic kidney disease (CKD) have evolved over time, but current international guidelines define this condition as decreased kidney function shown by glomerular filtration rate (GFR) of less than 60 mL/min per 1·73 m 2 , or markers of kidney damage, or both, of at least 3 months duration, regardless of the underlying cause. Diabetes and hypertension are the main causes of CKD in all high-income and middle-income countries, and also (...) measured either via exogenous markers (eg, DTPA, iohexol), or estimated using equations. Presence of proteinuria is associated with increased risk of progression of CKD and death. Kidney biopsy samples can show definitive evidence of CKD, through common changes such as glomerular sclerosis, tubular atrophy, and interstitial fibrosis. Complications include anaemia due to reduced production of erythropoietin by the kidney; reduced red blood cell survival and iron deficiency; and mineral bone disease

Lancet2016

77. Metabolically Healthy Obesity and Development of Chronic Kidney Disease

Metabolically Healthy Obesity and Development of Chronic Kidney Disease 27842407 2017 12 07 2018 11 13 1539-3704 165 10 2016 11 15 Annals of internal medicine Ann. Intern. Med. Metabolically Healthy Obesity and Development of Chronic Kidney Disease. 743 10.7326/L16-0407 Kahn Henry S HS From Centers for Disease Control and Prevention, Atlanta, Georgia. Pavkov Meda E ME From Centers for Disease Control and Prevention, Atlanta, Georgia. eng CC999999 Intramural CDC HHS United States Journal Article (...) Comment United States Ann Intern Med 0372351 0003-4819 AIM IM Ann Intern Med. 2016 Mar 1;164(5):305-12 26857595 Int J Obes (Lond). 2016 May;40(5):883-6 26841729 PLoS One. 2016 Jan 05;11(1):e0146057 26731527 Ann Intern Med. 2016 Mar 1;164(5):305-12 26857595 JAMA. 2015 Feb 24;313(8):837-46 25710660 Prog Cardiovasc Dis. 2014 Jan-Feb;56(4):369-81 24438728 Ann Intern Med. 2016 Nov 15;165(10 ):744-745 27842405 Body Mass Index Humans Obesity Obesity, Metabolically Benign Renal Insufficiency, Chronic 2016 11

Annals of Internal Medicine2016 Full Text: Link to full Text with Trip Pro

78. Sarcopenia, Obesity, and Mortality in US Adults With and Without Chronic Kidney Disease

Sarcopenia, Obesity, and Mortality in US Adults With and Without Chronic Kidney Disease 28439567 2018 11 13 2468-0249 2 2 2017 Mar Kidney international reports Kidney Int Rep Sarcopenia, obesity, and mortality in US adults with and without chronic kidney disease. 201-211 10.1016/j.ekir.2016.10.008 In pre-dialysis chronic kidney disease (CKD), the association of muscle mass with mortality is poorly defined, and no study has examined outcomes related to the co-occurrence of low muscle mass (...) Endocrinol Metab. 2015 Apr 15;308(8):E670-9 25670829 Am J Clin Nutr. 2007 Sep;86(3):633-8 17823427 J Gerontol A Biol Sci Med Sci. 2009 Apr;64(4):455-61 19196644 BMC Nephrol. 2014 Jul 08;15:108 25005601 J Am Soc Nephrol. 2006 Jun;17(6):1695-702 16641153 Am J Clin Nutr. 2006 Sep;84(3):475-82 16960159 J Am Soc Nephrol. 2014 Sep;25(9):2088-96 24652789 Cell Metab. 2013 Sep 3;18(3):368-79 24011072 appendicular skeletal muscle mass index body composition chronic kidney disease lean body mass sarcopenic obesity

Kidney international reports2016 Full Text: Link to full Text with Trip Pro

79. Downregulation of AdipoR1 is Associated with increased Circulating Adiponectin Levels in Serbian Chronic Kidney Disease Patients

Downregulation of AdipoR1 is Associated with increased Circulating Adiponectin Levels in Serbian Chronic Kidney Disease Patients 28670196 2018 11 13 1452-8258 35 4 2016 Oct Journal of medical biochemistry J Med Biochem Downregulation of AdipoR1 is Associated with increased Circulating Adiponectin Levels in Serbian Chronic Kidney Disease Patients. 436-442 10.1515/jomb-2016-0007 Since the rise in plasma adiponectin levels in chronic kidney disease (CKD) patients has not yet been elucidated, we (...) sought to investigate if patients on hemodialysis (HD) have altered expression of adiponectin receptors in peripheral blood mononuclear cells (PBMCs) compared to healthy subjects. This study included 31 patients with chronic kidney disease on HD and 33 healthy subjects (CG). Circulating adiponectin levels were measured by ELISA while AdipoR1 and AdipoR2 mRNA levels in PBMCs were determined by real-time PCR. Plasma adiponectin levels were significantly higher in patients compared to control group (P

Journal of medical biochemistry2016 Full Text: Link to full Text with Trip Pro

80. Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease

Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease 29142956 2018 11 13 2468-0249 2 2 2017 Mar Kidney international reports Kidney Int Rep Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease. 180-191 10.1016/j.ekir.2016.10.006 Chronic kidney disease (CKD) is often associated with poor hypertension control and treatment resistance, but whether CKD modifies (...) 22379110 Ann Intern Med. 2006 Aug 15;145(4):247-54 16908915 cardiovascular chronic kidney disease hypertension 2016 08 22 2016 10 15 2016 10 25 2017 11 17 6 0 2017 11 17 6 0 2017 11 17 6 1 epublish 29142956 10.1016/j.ekir.2016.10.006 S2468-0249(16)30162-0 PMC5678838

Kidney international reports2016 Full Text: Link to full Text with Trip Pro